Previous 10 | Next 10 |
home / stock / mkgaf / mkgaf news
2023-04-12 05:11:22 ET Merck KGaA ( OTCPK:MKGAF ) ( OTCPK:MKKGY ) said the U.S. Food and Drug Administration (FDA) placed a partial clinical hold on starting new patients on its multiple sclerosis therapy evobrutinib in the U.S. The German company's shares trading ...
2023-04-02 10:00:37 ET The deal spread in Pfizer's ( NYSE: PFE ) planned $43 billion purchase of Pfizer ( PFE ) is attractive with investors seeing decent upside upside from current levels, according to an Oppenheimer analyst. Seagen ( NASDAQ: SGEN ) is curre...
2023-03-29 15:05:26 ET Summary This portfolio uses historical performance and qualitative business traits to determine low-risk assets. These assets are leading their class and represent sectors that offer lower volatility. Backtesting proves that the constituents outperform t...
2023-03-27 12:49:07 ET German pharma Merck KGaA ( OTCPK:MKGAF ) announced Monday that it regained exclusive worldwide rights for bladder cancer therapy Bavencio (avelumab) after Pfizer ( NYSE: PFE ) ended a multi-year agreement. Bavencio is widely considered globally a...
2023-03-21 12:51:16 ET Vaccinex ( NASDAQ: VCNX ) said a phase 1b/2 trial of pepinemab in combination with avelumab as second line combination immunotherapy for patients with metastatic pancreatic adenocarcinoma (PDAC) has started. The main goal of the trial is to investiga...
The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2022 Q4 earnings call. For further details see: MERCK Kommanditgesellschaft auf Aktien 2022 Q4 - Results - Earnings Call Presentation
MERCK Kommanditgesellschaft auf Aktien (MKGAF) Q4 2022 Results Earnings Conference Call March 2, 2023, 08:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belén Garijo - Chair of the Executive Board and Chief Executive Officer Marcus Kuhn...
MERCK Kommanditgesellschaft auf Aktien press release ( OTCPK:MKGAF ): Q4 GAAP EPS of €2.32. Revenue of €5.66B (+8.6% Y/Y). For further details see: MERCK Kommanditgesellschaft auf Aktien GAAP EPS of €2.32, revenue of €5.66B
Summary Gossamer's TORREY showed stat sig PVR improvement, but the 6MWD was under what investors were hoping for; this led to a +70% decline in share price. Seralutnib is entering phase 3 with an adapted design (with more severe patients); although the success is less clear, any positiv...
Summary FSTX seems undervalued, even at the $7.12 takeover bid. The CFIUS is delaying the closure of the deal, citing review needed to allay US national security concerns. If the deal closes, the stock should rise 30%; if it fails, FSTX still has very valuable assets. The only r...
News, Short Squeeze, Breakout and More Instantly...
Merck Kgaa Company Name:
MKGAF Stock Symbol:
OTCMKTS Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...